概述
新闻资讯收录医药行业药品研发、注册审批、市场准入、关键技术进展、企业动态等资讯监测,并对提供资讯文章中医药领域核心抽取实体(如:企业、药物、靶点、适应症、时间、技术等)
数据结构及样例
JSON格式
{
"药品名称": [
"sotiburafusp alfa"
],
"企业名称": [
"上海华奥泰生物药业股份有限公司"
],
"适应症": [
"非小细胞肺癌",
"子宫内膜癌"
],
"靶点": [
"PD-L1",
"VEGF"
],
"来源": "微信公众号",
"来源链接": "https://mp.weixin.qq.com/mp/wappoc_appmsgcaptcha?poc_token=HGiLpmijXKLDukTvSoQ6OgaglnlSxeAY96CX3vsL&target_url=https%3A%2F%2Fmp.weixin.qq.com%2Fs%3F__biz%3DMzkwMTE4MTA0OA%3D%3D%26mid%3D2247484884%26idx%3D1%26sn%3D747a3290b0f8c67f231b4ecb9cac1669",
"标题": "【首发CSCO】周彩存教授口头汇报华海药业HB0025注射液肺癌研究成果",
"发布日期": "2025-08-19"
}